Exam 7 L. 7 Flashcards
Paraneoplastic syndromes
1) CANCER ASSOCIATED ALTERATIONS OCCURRING DISTANT TO TUMOR
2) typically result from tumor production of small molecules
- hormones, cytokines, peptides, enzymes
3) other causes = immune -related
- antibody cross-reactivity, immune complex development, autoimmune component
Clinical importance of Paraneoplastic Syndromes (PNS)
1) PNS often are the 1st sign of cancer!!*
- They may be a hallmark of certain types of tumor
2) PNS frequently parallel underlying malignancy
- treatment of tumor often resolves PNS
3)PNS MAY CAUSE GREATER MORBIDITY THAN PRIMARY TUMOR
Gastrointestinal manifestations of cancer
1) cachexia -wasting syndrome and weight loss
2) inappetence
3) protein losing enteropathy
4) Gastroduodenal ulceration
Cerenia (Maropitant): acts on..
1) Acts on the chemoreceptor trigger zone
- NK1 receptor
2) Emetic Center
- NK1 receptor
Metoclopramide acts on..
1) Chemoreceptor trigger zone
- D2 antagonist
2) Afferent neurons
- 5-HT3 receptors
NOTE: sedation +/-, behavioral changes
Ondansetron
Acts on chemoreceptor trigger zone
- 5-HT3 receptor
Control of food intake is complicated
1) increases feeding: Ghrelin
2) decreases feeding: stretch receptors, cholecystokinin, insulin, leptin
* ***a lot of negative input to the brain saying “not hungry” ===> many of these are upregulated in oncology patients
Capromorelin
1) the 1st FDA approved veterinary product for inappetence!
2) mimics the action of ghrelin*
- effect at appetite center to increase food intake
3) potent and selective growth hormone secretagogue receptor agonist = increases growth hormone secretion!!!!
- NOTE: because negative feedback loop is in place, these animals WON’T have abnormal growth
Gastroduodenal ulceration: mast cell tumors
1) mast cell tumors ==> hyperhistaminemia
- elevated plasma histamine = negative prognostic factor
2) histamine binds gastric H2 receptors ==> increased HCl***
- predisposes dog to gastric and duodenal ulcers
3) treatment: PPI, H2 blocker, misoprostol, sucralfate
NOTE: gastrinoma (gastrin secreting non-islet pancreatic tumor) can also cause G.I. ulceration
Endocrine manifestations of cancer
1) hypercalcemia
2) hypoglycemia
Causes of hypercalcemia
H-hyperparathyroidism A-Addison's disease (hypoadrenocortiscism) R-renal disease D-hypervitaminosis D I-idiopathic (cats) O-osteolysis (not common) N-neoplasia**(very common!) S-Systemic granulomatous disease
NOTE: most significant levels of hypercalcemia are seen with:
- malignancy/neoplasia
- primary hyperparathyroidism
- vitamin D toxicity
What is the number 1 cause of hypercalcemia in dogs?
CANCER!!
1) neoplasia is diagnosed in approximately 2/3 of dogs with hypercalcemia
- lymphoma: 10-35%
- apocrine gland anal sac adenocarcinoma (AGASACA)
- multiple myeloma
- ANY tumor can potentially cause hypercalcemia!
CATS: ~10-30% have hypercalcemia with neoplasia
- lymphoma
- squamous cell carcinoma (usually oral)
How do tumors cause hypercalcemia of malignancy?
-Most common cause of pathologic hypercalcemia in dogs and cats**
1) Ectopic production of parathyroid hormone (PTH) or PTH-related peptide (PTH-rp)
Clinical signs of hypercalcemia
1) PU/PD*
2) listlessness
3) urinary incontinence (secondary to PU/PD)
4) weakness
5) exercise intolerance
6) inappetence
NOTE: if you can’t find cause for hypercalcemia, remember to do a rectal exam! (AGASACA)
Therapy for hypercalcemia
1) IV fluid therapy (0.9% NaCl)
- Saline diuresis (2-3x maintenance): it will increase calcium excretion in kidneys
2) diuretic therapy (furosemide)
- IF and ONLY IF fluid deficits have been replaced
3) glucocorticoid therapy (prednisone)
- IF and ONLY IF diagnosis has been made (prednisone will kill lymphoma cells => makes it hard to get diagnosis!)
4) bisphosphonates: decrease osteoclast resorption
*determine/treat underlying cause of hypercalcemia!